DIRECT BIOLOGICS LLC

In News

Acute Respiratory Distress Syndrome Market to Grow Steadily - GlobeNewswire

GlobeNewswire - Jun 03, 2026

AlloDirect Launches First Direct-to-Tissue-Bank Biologics Marketplace for Orthopedic Surgeons, ASCs, and Practices - Orthopedics This Week

Orthopedics This Week - Apr 24, 2026

Direct Biologics Announces Significant Survival Benefit with ExoFlo™ in its Phase 2 Randomized Clinical Trial - BioInformant

BioInformant - Jul 13, 2023

Direct Biologics Gets New Look in Noncompete, Trade Secrets Case - Bloomberg Law News

Bloomberg Law News - Apr 04, 2023

Direct Biologics Announces FDA Approval for Proceeding With Second ExoFlo IND for Post-Acute COVID-19 Syndrome and Chronic Post-COVID-19 Syndrome - newswire.com

newswire.com - Jul 20, 2021

Houston-based SPAC Good Works II aims to take Austin-based Direct Biologics public - The Business Journals

The Business Journals - Sep 29, 2022

Direct Biologics - The Pharma Letter

The Pharma Letter - Jun 30, 2024

Direct Biologics Receives FDA Approval to Initiate ‘EXIT COVID-19,’ a Phase II Investigational New Drug Trial with ExoFlo™ - BioInformant

BioInformant - Aug 02, 2020

Direct Biologics Announces First Patient Treated Under Phase II Expanded Access Protocol Using ExoFlo™ to Treat COVID-19 - newswire.com

newswire.com - Dec 30, 2020

Finding Irreparable Harm: 5th Circuit Vacates Refusal to Enter Preliminary Injunction - McGuireWoods

McGuireWoods - Apr 28, 2023

Tr1 Treg Therapy to be Evaluated in Trial for Crohn Disease - CGTLive®

CGTLive® - Aug 11, 2024

Alphyn Closes $25M Oversubscribed Series B Financing Round to Advance Dermatology Pipeline - PR Newswire

PR Newswire - Dec 12, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment